Skip to content

Study · Not a test of the peptide alone · 1987

2 results

[Immunocorrective therapy of the traumatic syndrome].

Saakov BA, Belovolova RA, Bakhutashvili VI

Biulleten' eksperimental'noi biologii i meditsiny1 Jul 1987

PMID3497673 (opens in a new tab)DOI10.1007/bf00841910 (opens in a new tab)PepBankPUB-03497673
Publisher pagePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone2

In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymalin.

  1. 01AnimalNot a test of Thymalin aloneAnimal study (in vivo)Efficacy outcome

    In rats with traumatic syndrome, thymalin with plaferon doubled survival within the first 7 days.

    In plain wordsIn rats with traumatic syndrome, thymalin with plaferon doubled survival within the first 7 days.

    Peptide
    Thymalin
    Outcome
    IncreaseSurvival
    Study

    ratn: not reported in source

    Traumatic syndrome in Wistar male rats
    Outcome group
    Mortality · Whole body

    Source sentences

    Summary
    The combined application of thymalin and plaferon has increased the survival rate twice within the first 7 days.
    1 context sentence
    Summary · context
    Traumatic shock was induced by Kennon's method in Wistar male rats weighing 200-250 g.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

  2. 02AnimalNot a test of Thymalin aloneAnimal study (in vivo)Mechanism

    In rats, thymalin with plaferon showed its strongest immunomodulation in T-cell populations and serum lysozyme activity on the 7th day.

    In plain wordsIn rats, thymalin with plaferon showed its strongest immune effects in T cells and serum lysozyme activity.

    Peptide
    Thymalin
    Outcome
    Direction not reportedImmunomodulation
    Study

    ratn: not reported in source

    Traumatic syndrome in Wistar male rats
    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    Immunomodulating effect of the combined application of thymalin and plaferon on the 7th day of traumatic syndrome was most marked at the level of total T-lymphocyte population, theophylline-sensitive T suppressors and lysozyme blood serum activity.
    1 context sentence
    Summary · context
    Traumatic shock was induced by Kennon's method in Wistar male rats weighing 200-250 g.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.